Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.

Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.

We studied repeated measurements of CD4 cell counts on 5739 HIV-1-infected individuals with reliably estimated dates of seroconversion (SC) aged > or =15 years at SC prior to initiation of highly active antiretroviral therapy (HAART) or AIDS using random effects models. Estimated CD4 cell cou...

Full description

Bibliographic Details
Main Author:	CASCADE Collaboration
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?
by: Concerted Action on SeroConversion to AIDS and Death in Europe (CASCADE Collaboration)
Published: (2001)

Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection.
by: Sara Lodi, et al.
Published: (2013-01-01)

Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort
by: Van Santen, D, et al.
Published: (2019)

Estimation of the Seroconversion Duration of HIV-1 Antibodies in Individuals With Recent Infection in China
by: Wen-Hua Kong, et al.
Published: (2019-06-01)

Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.
by: Bhaskaran, K, et al.
Published: (2004)

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion
by: Stirrup, O, et al.
Published: (2017)

Estimation of time of HIV seroconversion using a modified CD4 depletion model.
by: Viviane D Lima, et al.
Published: (2021-01-01)

Incidence of Infection among Subjects with Seroconversion
by: Young Jung Kim, et al.
Published: (2022-01-01)

Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion.
by: Del Amo, J, et al.
Published: (2003)

Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates.
by: Touloumi, G, et al.
Published: (2004)

Early changes in the CD8 T Cell immunodominance hierarchy in primary HIV infection prior to seroconversion
by: Keane N, et al.
Published: (2012-09-01)

Imputation of the Date of HIV Seroconversion in a Cohort of Seroprevalent Subjects: Implications for Analysis of Late HIV Diagnosis
by: Paz Sobrino-Vegas, et al.
Published: (2012-01-01)

Multilevel ordinal model for CD4 count trends in seroconversion among South Africa women
by: Zelalem G. Dessie, et al.
Published: (2020-06-01)

Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
by: Qian Zhou, et al.
Published: (2023-04-01)

CMV seroconversion in pregnants and the incidence of congenital CMV infection
by: Ali Satilmiş, et al.
Published: (2007-01-01)

How soon after HIV seroconversion is antiretroviral therapy initiated?
by: Babiker, A, et al.
Published: (1999)

Sustained Mpox Proctitis with Primary Syphilis and HIV Seroconversion, Australia
by: Rachel M. Burdon, et al.
Published: (2023-03-01)

Measles mimicking HIV seroconversion syndrome: a case report
by: Brook Gary, et al.
Published: (2010-02-01)

Penile bacteria associated with HIV seroconversion, inflammation, and immune cells
by: Jessica L. Prodger, et al.
Published: (2021-04-01)

Healthcare Worker Seroconversion in SARS Outbreak
by: Pierce K. H. Chow, et al.
Published: (2004-02-01)

Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters.
by: Bhaskaran, K, et al.
Published: (2004)

Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic Individuals
by: S. Thasneem Banu, et al.
Published: (2023-03-01)

Prevalence, incidence and seroconversion of HIV and Syphilis infections among pregnant women of South Africa
by: Monjurul Hoque, et al.
Published: (2021-11-01)

Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.
by: Kaul, R, et al.
Published: (2001)

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.
by: Porter, K, et al.
Published: (2003)

High level of plasma TILRR protein is associated with faster HIV seroconversion
by: Mohammad Abul Kashem, et al.
Published: (2022-04-01)

Misuse of PrEP and atypical HIV seroconversion: about a case
by: Hélène Laroche, et al.
Published: (2018-05-01)

Towards estimation of HIV-1 date of infection: a time-continuous IgG-model shows that seroconversion does not occur at the midpoint between negative and positive tests.
by: Helena Skar, et al.
Published: (2013-01-01)

HIV Seroconversion in blood donors from the coordinating blood bank in the State of Pará
by: Andrea Silvestre Lobão Costa, et al.
Published: (2011-10-01)

Bilateral lower motor neuron facial nerve palsy due to HIV seroconversion
by: R Dolan, et al.
Published: (2011-04-01)

HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP)
by: Zorrilla CD, et al.
Published: (2018-04-01)

Serosorting is associated with a decreased risk of HIV seroconversion in the EXPLORE Study Cohort.
by: Susan S Philip, et al.
Published: (2010-09-01)

Determinants of response to first HAART regimen in antiretroviral-naive patients with an estimated time since HIV seroconversion.
by: Thiébaut, R, et al.
Published: (2006)

A Rare Case of Hepatitis Delta Co-Infection with Hbsag Seroconversion
by: Tuna Demirdal, et al.
Published: (2015-09-01)

Seroconversion following anal and genital HPV infection in men: The HIM study
by: Anna R. Giuliano, et al.
Published: (2015-12-01)

John Cunningham Virus seroconversion during natalizumab treatment
by: Erica Freire de Vasconcelos-Pereira, et al.
Published: (2024-11-01)

Measles Vaccine : A Study On Seroconversion And Side Effects
by: Malik Abida, et al.
Published: (1998-01-01)

Modeling of the combined dynamics of leptospirosis transmission and seroconversion in herds
by: Sudarat Chadsuthi, et al.
Published: (2022-09-01)

Toxoplasma gondii-associated Placentitis in the absence of maternal seroconversion
by: Christen Rune Stensvold, et al.
Published: (2022-11-01)

Seroconversion stages COVID19 into distinct pathophysiological states
by: Matthew D Galbraith, et al.
Published: (2021-03-01)